AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
Share:
More In Business
Be Prepared for No Rate Cuts in 2024
With stubborn inflation sticking at about 2.8%, there’s a chance that the Fed won’t cut rates this year. That might be the smarter choice in the long run.
The 2024 Election Will Impact the Economy – But Not the Way You Think
While most of the focus is on the presidential race, it's Congress that really matters when it comes to market impact, this economist says.
Equinox & Function Health: Pioneering the Future of Wellness
The health and wellness industry is booming, expected to hit $14 trillion by 2032. Equinox teamed up with Function Health to revolutionize health optimization.
Big Business This Week: Is China’s Economy on the Ropes?
Abercrombie is back...but never fear Millennials, you don't have to wear low-rise jeans.
Will Mr. Musk Go to Washington? Joining Trump Could Make Trouble for X
CEO of tastytrade Scott Sheridan weighs in on the possibility of Elon Musk joining Trump’s administration, plus the DOJ’s suit against Ticketmaster.
Teeing Up Change: The 14-Year-Old CEO Revolutionizing Girls' Golf Apparel
Featherie, a line of sustainable and functional golf wear for girls, fills a void in the market, catering to the increasing number of female junior golfers.
The Economic ‘Pain’ Fed Chief Jerome Powell Warned About Is Here
Data shows the economy grew less than expected in the first three months of the year, as consumers became more price conscious and spent less.
Will Live Nation and Ticketmaster Actually Be Broken Up?
The CEO of LiveOne, Rob Ellin, discusses the DOJ's lawsuit against Live Nation and Ticketmaster, how will if affect you and the future of live events. Watch!
The Future of Ether ETFs After That SEC Ruling
CoinShares CEO, Jean-Marie Mognetti, joins Cheddar to discuss what's next for ether ETFs and other cryptocurrency after the SEC surprise ruling.
